Laval, Canada

Mario C Filion

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 88(Granted Patents)


Location History:

  • Montreal, CA (2001)
  • Laval, CA (2004 - 2015)

Company Filing History:


Years Active: 2001-2015

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mario C. Filion in Bacterial Research

Introduction: Mario C. Filion, based in Laval, Canada, is a distinguished inventor with a remarkable portfolio of 18 patents. His work primarily focuses on novel bacterial compositions that harness the power of ribonucleic acid (RNA) and cell walls, showcasing his commitment to advancing biomedicine and cancer treatment.

Latest Patents: Among his notable inventions is the patent for "Bacterial ribonucleic acid cell wall compositions and methods of making and using them." This patent details the development of innovative bacterial and mycobacterial compositions that contain RNA and cell walls. The unique compositions not only display immune-stimulating properties but also have significant anti-cancer activity, highlighting their potential therapeutic applications.

Career Highlights: Throughout his career, Mario Filion has made significant strides in the field of biotechnology. He has worked for prominent firms, including Bioniche Life Sciences Inc. and Bioniche Urology IP Inc., where he contributed his expertise in developing groundbreaking solutions in medical science.

Collaborations: Filion’s success is augmented by collaborations with notable professionals in the field, such as Nigel C. Phillips and Zdenek Richard Holan. These partnerships have facilitated the exchange of ideas and innovation, further enhancing his research and inventions.

Conclusion: Mario C. Filion exemplifies the spirit of innovation in the realm of microbial research. His contributions to the development of RNA-based compositions underscore the vital role that inventors play in shaping the future of medical science and improving healthcare outcomes. With his continued efforts, the potential for new treatments and therapies remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…